Addus HomeCare Corporation (ADUS) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$96.64
Price Target
$128.67
Target Range
$112.00 — $139.00
Analyst Rating
Buy
Forward P/E14.3x
Trailing P/E18.5x
Forward PEG0.71
Implied Growth+27.7%
Median Target$135.00
Analyst Spread21.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$112
+15.9%
Consensus
$129
+33.1%
Bull Case
$139
+43.8%
Valuation Model TargetsConfidence: 81/100
Bear$41
Base$131
Bull$143
ADUS Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Addus HomeCare Corporation (ADUS) has a Wall Street consensus price target of $128.67, based on estimates from 15 covering analysts. With the stock currently trading at $96.64, this represents a potential upside of +30.7%. The company has a market capitalization of $1.80B.
Analyst price targets range from a low of $112.00 to a high of $139.00, representing a 21% spread in expectations. The median target of $135.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 13 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ADUS trades at a trailing P/E of 18.5x and forward P/E of 14.3x. The forward PEG ratio of 0.71 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +27.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $131.20, with bear and bull scenarios of $41.23 and $142.85 respectively. Model confidence stands at 81/100, indicating high predictability in the company's fundamentals.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+15.2%
Avg Forward P/E42.9x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HCSGHealthcare Services Group, Inc. | $1.6B | $22.07 | $24.50 | +12.7% | Hold | 20.3x | 15 |
 ENSGThe Ensign Group, Inc. | $10.3B | $175.93 | $222.33 | +26.4% | Buy | 23.4x | 13 |
 SGRYSurgery Partners, Inc. | $1.9B | $14.59 | $18.60 | +30.4% | Buy | 37.9x | 22 |
 ALHCAlignment Healthcare, Inc. | $3.7B | $18.14 | $24.83 | +35.7% | Buy | 141.3x | 16 |
 PNTGThe Pennant Group, Inc. | $1.1B | $32.53 | $39.00 | +24.0% | Buy | 23.7x | 7 |
 CCRNCross Country Healthcare, Inc. | $326M | $10.11 | $10.61 | -0.6% | Hold | 109.1x | 14 |
 UNHUnitedHealth Group Incorporated | $333.4B | $367.28 | $385.43 | +5.9% | Buy | 19.9x | 52 |
 CVSCVS Health Corporation | $110.4B | $86.86 | $95.20 | +18.0% | Buy | 11.3x | 41 |
 HUMHumana Inc. | $29.6B | $246.33 | $246.00 | +2.7% | Hold | 26.8x | 44 |
 CNCCentene Corporation | $27.3B | $55.31 | $51.00 | -3.7% | Buy | 15.7x | 43 |
Upside Potential Comparison
ALHCSGRYENSGPNTGCVSHCSGUNHHUMSee ADUS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADUS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ADUS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonADUS — Frequently Asked Questions
Quick answers to the most common questions about buying ADUS stock.
What is the ADUS stock price target for 2026?
The consensus Wall Street price target for ADUS is $128.67, representing 30.7% upside from the current price of $96.64. With 15 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is ADUS a buy, sell, or hold?
ADUS has a consensus rating of "Buy" based on 15 Wall Street analysts. The rating breakdown is predominantly bullish, with 13 Buy/Strong Buy ratings. The consensus 12-month price target of $128.67 implies 30.7% upside from current levels.
Is ADUS stock overvalued or undervalued?
With a forward P/E of 14.283x, ADUS trades at a relatively low valuation. The consensus target of $128.67 implies 30.7% appreciation, suggesting meaningful undervaluation.
How high can ADUS stock go?
The most bullish Wall Street analyst has a price target of $139 for ADUS, while the most conservative target is $112. The consensus of $128.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $143 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover ADUS stock?
ADUS is well covered by analysts, with 15 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 13 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ADUS stock forecast?
The 12-month ADUS stock forecast based on 15 Wall Street analysts shows a consensus price target of $128.67, with estimates ranging from $112 (bear case) to $139 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $131, with bear/bull scenarios of $41/$143.
What is ADUS's fair value based on fundamentals?
Our quantitative valuation model calculates ADUS's fair value at $131 (base case), with a bear case of $41 and bull case of $143. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 81/100.
What is ADUS's forward P/E ratio?
ADUS trades at a forward P/E ratio of 14.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ADUS stock?
Wall Street analysts are very optimistic on ADUS, with a "Buy" consensus rating and $128.67 price target (30.7% upside). 13 of 15 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ADUS price targets vary so much?
ADUS analyst price targets range from $112 to $139, a 21% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $128.67 consensus represents the middle ground. Our model's $41-$143 range provides an independent fundamental perspective.